DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $11,872,000 | -18.5% | 40,475 | -8.6% | 0.50% | -9.6% |
| Q4 2021 | $14,574,000 | +13.4% | 44,298 | +4.9% | 0.55% | -6.8% |
| Q3 2021 | $12,856,000 | +15.7% | 42,228 | +2.0% | 0.59% | +15.2% |
| Q2 2021 | $11,108,000 | +13.3% | 41,393 | -5.0% | 0.51% | +5.1% |
| Q1 2021 | $9,803,000 | -48.5% | 43,553 | -50.0% | 0.49% | -7.8% |
| Q4 2020 | $19,045,000 | +103.4% | 87,069 | +100.2% | 0.53% | -4.3% |
| Q3 2020 | $9,365,000 | +24.3% | 43,492 | +2.1% | 0.55% | +14.5% |
| Q2 2020 | $7,534,000 | +35.2% | 42,605 | +5.8% | 0.48% | +10.8% |
| Q1 2020 | $5,574,000 | -57.9% | 40,270 | -54.7% | 0.44% | +3.8% |
| Q4 2019 | $13,227,000 | +104.7% | 88,815 | +98.5% | 0.42% | -1.6% |
| Q3 2019 | $6,463,000 | +0.9% | 44,745 | -0.1% | 0.43% | +0.9% |
| Q2 2019 | $6,404,000 | +12.4% | 44,810 | +3.8% | 0.42% | +10.2% |
| Q1 2019 | $5,697,000 | +29.7% | 43,150 | +1.3% | 0.38% | +13.3% |
| Q4 2018 | $4,393,000 | -3.5% | 42,600 | +1.7% | 0.34% | +14.2% |
| Q3 2018 | $4,550,000 | +13.4% | 41,870 | +3.0% | 0.30% | +8.8% |
| Q2 2018 | $4,012,000 | +5.1% | 40,660 | +4.3% | 0.27% | +0.4% |
| Q1 2018 | $3,817,000 | +14.6% | 38,980 | +8.6% | 0.27% | +15.3% |
| Q4 2017 | $3,331,000 | +11.6% | 35,885 | +3.1% | 0.24% | +8.3% |
| Q3 2017 | $2,986,000 | +3.9% | 34,815 | +2.2% | 0.22% | 0.0% |
| Q2 2017 | $2,874,000 | +6.8% | 34,055 | +8.2% | 0.22% | +1.9% |
| Q1 2017 | $2,692,000 | +17.8% | 31,475 | +7.2% | 0.21% | +12.7% |
| Q4 2016 | $2,285,000 | +70.5% | 29,350 | +71.6% | 0.19% | +67.3% |
| Q3 2016 | $1,340,000 | -22.4% | 17,100 | 0.0% | 0.11% | -24.2% |
| Q2 2016 | $1,727,000 | +6.5% | 17,100 | 0.0% | 0.15% | +7.2% |
| Q1 2016 | $1,622,000 | +1.2% | 17,100 | -0.9% | 0.14% | -0.7% |
| Q4 2015 | $1,602,000 | +29.2% | 17,250 | +18.6% | 0.14% | +23.9% |
| Q3 2015 | $1,240,000 | +3.1% | 14,550 | +3.6% | 0.11% | +14.1% |
| Q2 2015 | $1,203,000 | – | 14,050 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |